Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status

BACKGROUND/AIMS: Antiviral therapy (AVT) reduces the risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B (CHB). This multicenter retrospective study investigated the effects of AVT and hepatitis B virus (HBV)-related factors on the risk of HCC development in a coh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gut Liver
Egile Nagusiak: Kim, Mi Na, Hwang, Seong Gyu, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Han, Kwang-Hyub, Kim, Seung Up, Ahn, Sang Hoon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Editorial Office of Gut and Liver 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430437/
https://ncbi.nlm.nih.gov/pubmed/30602075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18204
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak